Return to Clinical Trials Search Results

THEMIS A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus [THEMIS - effect of Ticagrelor on Health outcomes in diabEtes Mellitus patients Intervention Study]

The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with Type 2 Diabetes Mellitus

Phase

III

Recruitment Status

Past Studies

View on
ClinicalTrials.gov